We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$28.5M
(+9.6%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
243
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$3.29M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.96M |
| 3 |
Apple
AAPL
|
+$1.92M |
| 4 |
Vaxcyte
PCVX
|
+$1.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$5.11M |
| 2 |
Amazon
AMZN
|
+$4.12M |
| 3 |
Airbnb
ABNB
|
+$2.92M |
| 4 |
Analog Devices
ADI
|
+$2.79M |
| 5 |
KE Holdings
BEKE
|
+$2.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.8% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Healthcare | 19.26% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Guardant Health
GH
$22B
| $105K | 0.03% |
2,930
+144
| +5% | +$4.14K |
|
152
Jazz Pharmaceuticals
JAZZ
$16.3B
| $104K | 0.03% |
839
-14
| -2% | -$1.88K |
|
153
Automatic Data Processing
ADP
$107B
| $103K | 0.03% |
466
+341
| +273% | +$73.5K |
|
154
Roivant Sciences
ROIV
$26.2B
| $100K | 0.03% |
9,941
-335
| -3% | -$3K |
|
155
Lam Research
LRCX
$411B
| $97.9K | 0.03% |
1,520
+1,110
| +271% | +$62.6K |
|
|
ONC
156
BeOne Medicines Ltd
ONC
$40.6B
| $96.6K | 0.03% |
542
-35
| -6% | -$8.06K |
|
157
Medpace
MEDP
$16.9B
| $95.8K | 0.03% |
399
-21
| -5% | -$4.36K |
|
158
Amphenol
APH
$211B
| $85.1K | 0.03% |
2,000
| – | – |
|
159
TJX Companies
TJX
$171B
| $84.8K | 0.03% |
1,000
| – | – |
|
160
Ambarella
AMBA
$3.67B
| $83.7K | 0.03% |
1,000
| – | – |
|
161
Exelixis
EXEL
$12.7B
| $81.6K | 0.03% |
4,268
-123
| -3% | -$2.37K |
|
|
ITCI
162
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $79.7K | 0.02% |
1,258
-25
| -2% | -$1.56K |
|
163
CSX Corp
CSX
$92.8B
| $78.2K | 0.02% |
2,294
+1,670
| +268% | +$52.8K |
|
164
Align Technology
ALGN
$12.3B
| $77.4K | 0.02% |
219
-4,858
| -96% | -$1.55M |
|
165
Ionis Pharmaceuticals
IONS
$9.44B
| $76.9K | 0.02% |
1,875
-62
| -3% | -$2.38K |
|
166
KLA
KLAC
$273B
| $75.2K | 0.02% |
1,550
+1,130
| +269% | +$47.2K |
|
|
ATVI
167
DELISTED
Activision Blizzard
ATVI
| $74.8K | 0.02% |
887
+650
| +274% | +$52.6K |
|
|
ABCM
168
DELISTED
Abcam PLC
ABCM
| $72.2K | 0.02% |
2,952
+54
| +2% | +$932 |
|
169
Cadence Design Systems
CDNS
$90.1B
| $72.2K | 0.02% |
308
+225
| +271% | +$49K |
|
|
ISEE
170
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $71K | 0.02% |
1,805
-38
| -2% | -$1.34K |
|
171
Alkermes
ALKS
$8.42B
| $68.1K | 0.02% |
2,177
-50
| -2% | -$1.51K |
|
172
Monster Beverage
MNST
$89.1B
| $67.8K | 0.02% |
2,362
+1,730
| +274% | +$49.2K |
|
173
Ascendis Pharma A/S
ASND
$16.8B
| $66.8K | 0.02% |
748
-23
| -3% | -$2K |
|
174
O'Reilly Automotive
ORLY
$74.6B
| $65.9K | 0.02% |
1,035
+750
| +263% | +$45.8K |
|
|
IMGN
175
DELISTED
Immunogen Inc
IMGN
| $63.3K | 0.02% |
3,355
+364
| +12% | +$4.3K |
|
Similar funds
HA
JPM
NRI
CPO
LCI
GWM
JIP
RMC
China Universal Asset Management Company's Q2 2023 Portfolio in Review
As of Q2 2023, China Universal Asset Management Company held 465 positions worth $324M, up 9.6% from $295M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company's Q2 2023 filing shows 18 new, 159 increased, 243 reduced and 13 closed positions. Its largest new stake was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M. The largest sale was iQIYI, an estimated $5.11M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q2 2023 buy was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M.
- China Universal Asset Management Company added most to Alnylam Pharmaceuticals in Q2 2023, an estimated $1.96M increase.
- China Universal Asset Management Company's biggest Q2 2023 reduction was iQIYI, cutting an estimated $5.11M.
- China Universal Asset Management Company fully exited Block Inc in Q2 2023, selling an estimated $1.35M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $324M portfolio in Q2 2023.
- China Universal Asset Management Company opened 18 new positions and closed 13 in Q2 2023.
- China Universal Asset Management Company's portfolio value rose 9.6% quarter-over-quarter to $324M.
Based on China Universal Asset Management Company's 13F filing for Q2 2023, filed 28 Jul 2023.